SELLAS Announces Positive Follow-Up Phase 1/2 Clinical Data for Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)

    NEXT STORY
    Novavax Advances Development of Novel COVID-19 Vaccine
    PREV STORY
    CHF Solutions receives 510(k) clearance for Aquadex SmartFlow™ system in Pediatric Patients Weighing 20kg or More
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Novartis first-in-class Cosentyx® approved in China for psoriasis patients

    author_avatar
    NASDAQ Market News

    Foamix Pharmaceuticals Announces Publication of Abstract on FDX-104 in the Treatment of EGFRI Induced Rash for the 2016 ASCO Meeting

    REHOVOT, Israel and BRIDGEWATER, N.J., May 31, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. ...

    author_avatar
    NASDAQ Market News

    University Hospitals significantly expands and extends relationship with Allscripts

    CHICAGO, March 29, 2016 (GLOBE NEWSWIRE) -- University Hospitals (UH), in Cleveland, Ohio expanded ...

    author_avatar
    NASDAQ Market News